Delivery Order SPE2DB20D7066-SPE2DB25FC4NY
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for the supply of Rifampin 300 mg capsules (60-count units) at a ceiling value of $1,720.96. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for ultimate completion by July 29, 2025. The award falls under AmerisourceBergen's larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules. The order is valued at $6,351.40 and has a period of performance through August 30, 2024. This delivery order is placed against an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which has a potential value of up to $999,999,999 and provides a broad range of pharmaceutical and medical supplies to military...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $2,132.20, is for the delivery of 60 capsules of the pharmaceutical product Rifampin 300 mg. The contract is a firm fixed price delivery order with a period of performance through March 29, 2024. Amerisourcebergen Drug Corp, based in...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,061.60, is for the delivery of Rifampin 150 mg capsules. It is a firm fixed-price delivery order contract with an ultimate completion date of November 10, 2022. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen is the prime contractor, and the contract is part of a larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the provision of Rifampin 300 mg capsules. The contract, valued at $1,282.42, has a period of performance through February 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,187.50 firm-fixed-price contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a medication. The order has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. The company also holds a significant...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Rifampin 300 mg capsules. The firm-fixed-price contract has a ceiling value of $10,688.90 and a completion date of November 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides $27,852.48 for the delivery of 4,564,840,981 units of Rifampin 300 mg capsules. The contract is a firm-fixed-price delivery order with a completion date of June 10, 2024, awarded by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,941.31 firm fixed-price delivery order contract is for the supply of RIFAMPIN 300 MG CAPSULE 30S, a critical pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Rifampin 300 mg capsules in unit dose packaging (100 count) under a firm fixed price contract valued at $3,300.54. This non-set-aside award is scheduled for completion by August 15, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's pharmaceutical supply support...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4NYDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $2,953.93 by the Defense Logistics Agency (DLA) for the supply of Rifampin 150 mg capsules in quantities of 30, with an ultimate completion date of September 3, 2025. The contract employs firm fixed-price pricing and was competitively awarded without any set-aside designation. Performance will be executed from the company's Conshohocken, Pennsylvania location, which serves as its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The DLA's Medical Supply Chain relies on AmerisourceBergen as a critical vendor for pharmaceutical procurement supporting military and veteran healthcare systems. Through its prime IDC, the company supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency requirements and other federal healthcare systems. AmerisourceBergen's demonstrated capability in meeting federal procurement standards through open competition positions it as a key partner in the DLA Troop Support's pharmaceutical distribution network, with plans underway for the agency to establish next-generation Pharmaceutical Prime Vendor Global Program contracts involving multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/2/25 |